Independent Pharmacies Show Remarkable Resilience and Set for Expanded Market Presence
The 2024 NCPA Digest reveals not just resilience among independent pharmacies, but signals an upcoming shift in market dynamics that could significantly boost their presence. With major chains announcing substantial closures—including 900 CVS locations, 1,200 Walgreens stores, and 500 Rite Aid outlets—independent pharmacies' current 35 percent market share is positioned to grow markedly in the coming months.
A Growing Force in Pharmacy Care
Independent pharmacies currently represent 35 percent of all retail pharmacies in the United States, and this share is set to expand as major chains reduce their footprint. The long-standing fact that no single pharmacy chain has more stores than all independents combined will become even more pronounced as chain pharmacies consolidate operations, potentially creating new opportunities for independent operators to serve communities in need of accessible healthcare services.
Building on Strong Foundations
This market evolution comes at a time when independent pharmacies have already proven their adaptability through comprehensive service offerings:
• 91% provide flu immunizations
• 91% offer non-flu immunizations
• 81% deliver medication therapy management
• 64% perform blood pressure monitoring
• 52% serve long-term care patients
• 47% offer compounding services
Unwavering Community Commitment
Even as they prepare for potential expansion, independent pharmacies maintain their deep community bonds:
• 60% of owners donate to five or more local organizations
• 61% contribute more than $3,000 annually to community organizations
• They represent a robust $94.9 billion marketplace, with opportunities for growth as they fill gaps left by chain closures
Strength Through Strategic Networks
Over 3,400 pharmacies have joined CPESN® USA, making it the country's fourth-largest single-contract organization of pharmacy providers. This collaborative approach positions independent pharmacies to potentially absorb market share from closing chain locations while maintaining high service standards.
Strategic Adaptation to Market Changes
Independent pharmacies continue to demonstrate their resilience through strategic business model adjustments. Maintaining a strong generic dispensing rate of 83% while adapting to new market demands, including the rise of specialized medications like GLP-1 agonists, showcases their operational flexibility. This adaptability will be crucial as they expand into areas previously served by chain pharmacies.
Positioned for Future Growth
The resilience of independent pharmacies has set the stage for potential expansion. As major chains reduce their footprint, independent pharmacies are uniquely positioned to:
• Fill healthcare gaps in communities affected by chain closures
• Expand their market presence beyond the current 35% share
• Bring their community-focused approach to new neighborhoods
• Leverage their adaptable business models to serve diverse community needs
The combination of proven resilience, established community ties, and the upcoming market shifts created by chain pharmacy closures suggests independent pharmacies are not just surviving—they're positioning for significant growth. Their demonstrated ability to adapt while maintaining a strong community focus indicates they're well-prepared to seize the opportunities presented by this changing healthcare landscape.
Read the NCPA 2024 Digest Report here.
Interested in savings on prescription medications? RxPost can help you buy or sell excess drug inventory to improve your profits and offer better patient service. Learn more about RxPost here.